adipogenic differentiation medium (PromoCell)
95
Structured Review
PromoCell
adipogenic differentiation medium
Adipogenic Differentiation Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 72 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mesenchymal+stem+cell+adipogenic+differentiation+medium+2/Mesenchymal+Stem+Cell+Adipogenic+Differentiation+Medium+2/pmc13121900-119-5-9
Average 95 stars, based on 72 article reviews
Adipogenic Differentiation Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 72 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mesenchymal+stem+cell+adipogenic+differentiation+medium+2/Mesenchymal+Stem+Cell+Adipogenic+Differentiation+Medium+2/pmc13121900-119-5-9
Average 95 stars, based on 72 article reviews
adipogenic differentiation medium - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Cell Differentiation:Article Title: Rejuvenation of human mesenchymal stem cells using a nonintegrative and conditionally removable Sendai virus vector. Article Snippet: .. Commercially available differentiation kits (Promo Cell) were used for MSC differentiation and included the following: Recombinant:Article Title: CD146 + interstitial cells contribute to the dystrophic skeletal muscle phenotype in vitro. Article Snippet: .. The growth medium was replaced with one of the following media: 1) skeletal muscle differentiation medium (C-23061, Promocell), containing 5% FBS, 1% penicillinstreptomycim, 50 mg/ml fetuin, 10 ng/ml epidermal growth factor (EGF), 1 ng/ml fibroblast growth factor (FGF), 10 ug/ml insulin and 0,4 ug/ml dexamethasone; 2) Article Title: CD146 + interstitial cells contribute to the dystrophic skeletal muscle phenotype in vitro Article Snippet: .. The growth medium was replaced with one of the following media: (1) skeletal muscle differentiation medium (C-23061, Promocell), containing 5% FBS, 1% penicillin-streptomycim, 50 mg/ml fetuin, 10 ng/ml epidermal growth factor (EGF), 1 ng/ml fibroblast growth factor (FGF), 10 ug/ml insulin and 0,4 ug/ml dexamethasone; (2) |